These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2109714)

  • 41. Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning.
    Luo B; Nanji SA; Schur CD; Pawlick RL; Anderson CC; Shapiro AM
    Transplantation; 2005 Aug; 80(3):370-7. PubMed ID: 16082333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of streptozotocin-induced diabetes mellitus in rats by transplantation of islet cells from two major histocompatibility complex disparate rats in combination with intra bone marrow injection of allogeneic bone marrow cells.
    Taira M; Inaba M; Takada K; Baba S; Fukui J; Ueda Y; Kwon AH; Hisha H; Kamiyama Y; Ikehara S
    Transplantation; 2005 Mar; 79(6):680-7. PubMed ID: 15785374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
    Lakey JR; Singh B; Warnock GL; Rajotte RV
    Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts.
    Li H; Inverardi L; Molano RD; Pileggi A; Ricordi C
    Transplantation; 2003 Apr; 75(7):966-70. PubMed ID: 12698081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
    Fu F; Hu S; Deleo J; Li S; Hopf C; Hoover J; Wang S; Brinkmann V; Lake P; Shi VC
    Transplantation; 2002 May; 73(9):1425-30. PubMed ID: 12023620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice.
    Guo Z; Wu T; Sozen H; Pan Y; Heuss N; Kalscheuer H; Sutherland DE; Blazar BR; Hering BJ
    Transplantation; 2003 Apr; 75(7):909-15. PubMed ID: 12698073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The nature of tolerance in adult recipient mice made tolerant of alloantigens with supralethal irradiation followed by syngeneic bone marrow cell transplantation plus injection of F1 spleen cells.
    Tomita Y; Himeno K; Mayumi H; Tokuda N; Nomoto K
    Transplantation; 1989 Jun; 47(6):1021-9. PubMed ID: 2660340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts.
    Drizlikh G; Schmidt-Sole J; Yankelevich B
    J Exp Med; 1984 Apr; 159(4):1070-82. PubMed ID: 6142918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of the role of major histocompatibility complex in type 1 diabetes recurrence after islet transplantation.
    Young HY; Zucker P; Flavell RA; Jevnikar AM; Singh B
    Transplantation; 2004 Aug; 78(4):509-15. PubMed ID: 15446308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mixed xenogeneic chimerism (mouse+rat-->mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts.
    Li H; Ricordi C; Demetris AJ; Kaufman CL; Korbanic C; Hronakes ML; Ildstad ST
    Transplantation; 1994 Feb; 57(4):592-8. PubMed ID: 8116047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone marrow-derived T lymphocytes responsible for allograft rejection.
    Senjanović M; Marusić M
    Cell Immunol; 1984 Aug; 87(1):225-30. PubMed ID: 6204774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of peripheral immune tolerance uncovers a mouse strain-dependent in situ type of graft tolerance.
    Mysliwietz J; Thierfelder S
    Eur J Immunol; 1999 Jan; 29(1):150-5. PubMed ID: 9933096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes.
    Su M; Lin Y; He Z; Lai L
    Stem Cell Res Ther; 2019 Aug; 10(1):239. PubMed ID: 31387620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Restriction specificity of virus-specific cytotoxic T cells from thymectomised irradiated bone marrow chimeras reconstituted with thymus grafts.
    Zinkernagel RM
    Thymus; 1981 Apr; 2(6):321-7. PubMed ID: 6168044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved.
    Mathieu C; Casteels K; Bouillon R; Waer M
    J Immunol; 1997 Feb; 158(3):1453-7. PubMed ID: 9013991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone marrow-derived cells are essential for intrathymic deletion of self-reactive T cells in both the host- and donor-derived thymocytes of fully allogeneic bone marrow chimeras.
    Yoshikai Y; Ogimoto M; Matsuzaki G; Nomoto K
    J Immunol; 1990 Jul; 145(2):505-9. PubMed ID: 2114441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of T cell depletion in radiation bone marrow chimeras. II. Requirement for allogeneic T cells in the reconstituting bone marrow inoculum for subsequent resistance to breaking of tolerance.
    Sykes M; Sheard MA; Sachs DH
    J Exp Med; 1988 Aug; 168(2):661-73. PubMed ID: 3045249
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody.
    Cavazzana-Calvo M; Sarnacki S; Haddad E; De Coene C; Calise D; Yvon E; Cerf-Bensussan N; Fischer A
    Transplantation; 1995 Jun; 59(11):1576-82. PubMed ID: 7778173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.